Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Trijau

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Joint Bone Spine|May 30, 2016
Bone infarcts: Unsuspected gray areas?Pierre Lafforgue, Sophie Trijau
Rheumatology (Oxford, England)|April 3, 2010
Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysisCécile Escalas, Sophie Trijau, Maxime Dougados
Rheumatology (Oxford, England)|September 20, 2022
Absence of overexpression of KIR3DL2 on CD4+ T cells and NK cells in patients with axial spondyloarthritisGuillaume Larid, Sophie Trijau, Clothilde Barral, et al.
RMD Open|August 4, 2016
Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance databaseSophie Trijau, Gaëlle de Lamotte, Vincent Pradel, et al.
AIDS (London, England)|April 21, 2017
Frailty in HIV infected people: a new risk factor for bone mineral density lossSylvie Bregigeon, Anne Galinier, Olivia Zaegel-Faucher, et al.
JBMR Plus|May 7, 2025
Real-world efficacy and safety of burosumab in tumor-induced osteomalacia: case series from an early access programSimon Cadiou, Roland Chapurlat, Guillaume Couture, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Joint Bone Spine|May 30, 2016
Bone infarcts: Unsuspected gray areas?Pierre Lafforgue, Sophie Trijau
Rheumatology (Oxford, England)|April 3, 2010
Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysisCécile Escalas, Sophie Trijau, Maxime Dougados
Rheumatology (Oxford, England)|September 20, 2022
Absence of overexpression of KIR3DL2 on CD4+ T cells and NK cells in patients with axial spondyloarthritisGuillaume Larid, Sophie Trijau, Clothilde Barral, et al.
RMD Open|August 4, 2016
Osteoporosis prevention among chronic glucocorticoid users: results from a public health insurance databaseSophie Trijau, Gaëlle de Lamotte, Vincent Pradel, et al.
AIDS (London, England)|April 21, 2017
Frailty in HIV infected people: a new risk factor for bone mineral density lossSylvie Bregigeon, Anne Galinier, Olivia Zaegel-Faucher, et al.
JBMR Plus|May 7, 2025
Real-world efficacy and safety of burosumab in tumor-induced osteomalacia: case series from an early access programSimon Cadiou, Roland Chapurlat, Guillaume Couture, et al.
Pageof 1